Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti, Josef Leibold, Matthew J. Bott, et al.
Science (2018) Vol. 362, Iss. 6421, pp. 1416-1422
Open Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Raffaella Di Micco, Valery Krizhanovsky, Darren J. Baker, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 22, Iss. 2, pp. 75-95
Open Access | Times Cited: 1450
NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
Cell cycle control in cancer
Helen K. Matthews, Cosetta Bertoli, Robertus A.M. de Bruin
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 74-88
Open Access | Times Cited: 956
Senescence and the SASP: many therapeutic avenues
Jodie Birch, Jesús Gil
Genes & Development (2020) Vol. 34, Iss. 23-24, pp. 1565-1576
Open Access | Times Cited: 781
Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 751
Senolytic CAR T cells reverse senescence-associated pathologies
Corina Amor, Judith Feucht, Josef Leibold, et al.
Nature (2020) Vol. 583, Iss. 7814, pp. 127-132
Open Access | Times Cited: 724
Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget, Qihao Ren, Sheila A. Stewart
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 439-453
Closed Access | Times Cited: 647
Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 511
The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 442
Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 439
Targeting cell-cycle machinery in cancer
Jan M. Suski, Marcin Braun, Vladislav Strmiska, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 759-778
Open Access | Times Cited: 375
An atlas of healthy and injured cell states and niches in the human kidney
Blue B. Lake, Rajasree Menon, Seth Winfree, et al.
Nature (2023) Vol. 619, Iss. 7970, pp. 585-594
Open Access | Times Cited: 337
Targeting CDK4 and CDK6 in cancer
Shom Goel, Johann S. Bergholz, Jean J. Zhao
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 356-372
Open Access | Times Cited: 320
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, et al.
Cell (2020) Vol. 181, Iss. 2, pp. 424-441.e21
Open Access | Times Cited: 306
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 263
Cell cycle on the crossroad of tumorigenesis and cancer therapy
Jing Liu, Yunhua Peng, Wenyi Wei
Trends in Cell Biology (2021) Vol. 32, Iss. 1, pp. 30-44
Open Access | Times Cited: 261
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Pataje G.S. Prasanna, Deborah E. Citrin, Jeffrey Hildesheim, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 10, pp. 1285-1298
Open Access | Times Cited: 240
α-Ketoglutarate links p53 to cell fate during tumour suppression
John P. Morris, Jossie J. Yashinskie, Richard P. Koche, et al.
Nature (2019) Vol. 573, Iss. 7775, pp. 595-599
Open Access | Times Cited: 237
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall, Pascale André, Amir Horowitz, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 235
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Tareq Saleh, Sarah Bloukh, Valerie J. Carpenter, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 822-822
Open Access | Times Cited: 225
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Inés Marín, Olga Boix, Andrea García-Garijo, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 410-431
Open Access | Times Cited: 187
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 183
Immunomodulation by targeted anticancer agents
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, et al.
Cancer Cell (2020) Vol. 39, Iss. 3, pp. 310-345
Open Access | Times Cited: 179
Senolytics and senostatics as adjuvant tumour therapy
Susan Short, Edward Fielder, Satomi Miwa, et al.
EBioMedicine (2019) Vol. 41, pp. 683-692
Open Access | Times Cited: 171
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy
Erik S. Knudsen, Steven C. Pruitt, Pamela A. Hershberger, et al.
Trends in cancer (2019) Vol. 5, Iss. 5, pp. 308-324
Open Access | Times Cited: 162
Page 1 - Next Page

Scroll to top